Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Sight Sciences's Return On Capital Employed Overview

According to data from Benzinga Pro, during Q4, Sight Sciences's (NASDAQ:SGHT) reported sales totaled $14.69 million. Despite a 7.18% increase in earnings, the company posted a loss of $15.94 million.

Benzinga

One Stop Systems's Return On Capital Employed Insights

One Stop Systems (NASDAQ:OSS) brought in sales totaling $17.78 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 139.38%, resulting in a loss of $386.24 thousand.

Benzinga

Aptevo Therapeutics Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data, during Q4, Aptevo Therapeutics (NASDAQ:APVO) posted sales of $3.67 million. Earnings were up 10.36%, but Aptevo Therapeutics still reported an overall loss of $6.27 million.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

HOOKIPA Pharma's Return On Capital Employed Overview

Benzinga Pro data, HOOKIPA Pharma (NASDAQ:HOOK) reported Q4 sales of $3.90 million. Earnings fell to a loss of $21.23 million, resulting in a 5.96% decrease from last quarter.

Benzinga

AutoWeb Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data, during Q4, AutoWeb (NASDAQ:AUTO) posted sales of $17.80 million. Earnings were up 14.63%, but AutoWeb still reported an overall loss of $2.61 million.

Benzinga

Co-Diagnostics's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Co-Diagnostics (NASDAQ:CODX) posted Q4 earnings of $7.50 million, an increase from Q3 of 34.66%. Sales dropped to $20.40 million, a 32.22% decrease between quarters.

Benzinga

Why Cyren Stock Is Trading Lower Today

CYREN Ltd (NASDAQ: CYRN) is trading lower Friday after the company reported worse-than-expected revenue results. Cyren said fourth-quarter revenue declined from $8.4 million to $7.4 million year-over-year, which came in below the $7.77 million estimate.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Here's Why Canaccord Is Bullish On This Cryptocurrency Mining Company

Canaccord Genuity analyst Joseph Vafi initiated coverage of HIVE Blockchain Technologies Ltd (NASDAQ:HIVE) with a Buy rating and a $2.80 price target, suggesting an upside of 27%. Digital assets, especially Bitcoin and Ethereum, successfully exited another test of their resiliency in the face of recent market volatility. Vafi expects miners to benefit if bitcoin prices…

Benzinga

YTRA: Yatra Online Files to IPO on India Exchanges

By Lisa Thompson NASDAQ:YTRA READ THE FULL YTRA RESEARCH REPORT

Benzinga

Netflix Snaps Its Third Gaming Studio

Netflix Inc (NASDAQ:NFLX) acquired Boss Fight Entertainment, a mobile game developing studio, Venture Beat reports. The financial terms of the transaction remain undisclosed. Boss Fights joined Netflix's two other game studio acquisitions after Night School Studio and Next Games, Variety reports. Also Read: Needham Sees Netflix Losing Out To Amazon, Disney, Apple and Other Streaming Rivals…

Benzinga

Benzinga's Daily Brief On Trending Tickers For March 25, 2022: Tilray, Sundial, Bed Bath & Beyond, And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

Benzinga

Why Cutera's Shares Are Soaring Today

The FDA has granted 510(k) clearance to Cutera Inc's (NASDAQ:CUTR) AviClear for acne. The Company notes that AviClear is the first and only energy-based device to receive this designation to treat mild, moderate, and severe acne. AviClear is a laser treatment that offers a safe, prescription-free solution for acne. In addition to reducing existing acne,…

Benzinga

(ASML) - Analyzing Asml Holding N.V. - New York Registry Shares's Short Interest

Asml Holding N.V. - New York Registry Shares's (NASDAQ:ASML) short percent of float has risen 10.34% since its last report. The company recently reported that it has 1.27 million shares sold short, which is 0.32% of all regular shares that are available for trading.

Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

Benzinga

11 Industrials Stocks Moving In Friday's Pre-Market Session

Benzinga

9 Information Technology Stocks Moving In Friday's Pre-Market Session

Benzinga

Jazz Pharma Getting New State-Of-The-Art Facility For Cannabis-Based Research And Production

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and its subsidiary, GW Pharmaceuticals have begun construction of its new, state-of-the-art manufacturing facility at Kent Science Park (KSP) in Sittingbourne, UK, with an investment of over $100 million.&nb

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Insiders Buying These 5 Penny Stocks

The Dow Jones surged around 350 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or…

Benzinga

Why The Honest Co Stock Is Falling Today

The Honest Co Inc (NASDAQ: HNST) is trading lower Friday morning after the company reported worse-than-expected financial results.

Benzinga

ADMA Biologics' Q4 Top-Line Surpass Estimates, Concludes $175M Debt Refinancing

ADMA Biologics Inc (NASDAQ: ADMA) closed a debt refinancing with Hayfin Capital Management of $150 million, and up to an additional $25 million tied to specific revenue targets during 2022.

Benzinga

Here's Why Bed Bath & Beyond Stock Is Trading Higher Today

Bed Bath & Beyond Inc. (NASDAQ: BBBY) shares are trading higher after the company reported a cooperation agreement with Ryan Cohen's RC Ventures.

Benzinga

Children's Place And 2 Other Stocks Bought By Insiders

Although US stock futures traded higher this morning on Friday, there were a few notable insider trades.

Benzinga

Wells Fargo Sees 54% Downside In REE Automotive - Read Why

Wells Fargo analyst Colin Langan initiated coverage of REE Automotive Ltd (NASDAQ:REE) with an Underweight rating and $1 price target, implying a 54.55% downside. Langan said the total fetchable market by 2030 was much smaller than the company’s estimate of $700 billion. The analysts also added that REE will burn through half of its cash…

Benzinga

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Rising

Shares of several cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

1 … 768 769 770 771

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Jazz Pharmaceuticals plc

44 stories

Aurora Cannabis

33 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.